期刊文献+

肝门胆管癌预后的影响因素分析 被引量:9

Analysis on the influencing factor for the prognosis of hilar cholangiocarcinoma
下载PDF
导出
摘要 目的分析影响肝门胆管癌预后的因素。方法回顾分析我院自1999年10月至2008年5月期间71例肝门胆管癌病例资料。结果多因素生存回归分析提示,血清CEA水平(x2=14.56,P=0.004)、手术方式(x2=22.49,P<0.001)、TNM分期(x2=12.31,P=0.005)与肝门胆管癌预后显著相关。血清CEA升高者和正常者平均生存时间分别为(7.1±5.6)个月和(10.6±7.4)个月,存在统计学差异(P<0.05);根治性切除、姑息性切除、单纯引流及未经治疗者平均生存时间分别为(17.1±9.6)个月、(1 0.6±4.2)个月、(7.4±2.5)个月、(3.4±1.4)个月,存在统计学差异(P<0.0 5);I期、II期、II I期、IV a期、IV b期平均生存时间分别为(1 8.5±5.9)个月、(1 6.7±1 0.0)个月、(1 3.2±8.7)个月、(1 0.9±7.4)个月、(8.3±6.3)个月,存在统计学差异(P<0.05)。结论术前血清CEA正常、根治性手术切除、分期较早的患者肝门胆管癌预后相对较好。 Objective To analyze the prognostic factors of hilar cholangiocarcinoma.Methods Retrospective analysis was carried out for 71 cases of hilar cholangiocarcinoma admitted in our hospital from October 1999 to May 2008.Prognostic factors were analyzed.Results Multi-factor regression analysis revealed that 3 variables were significantly relative to the survival time of hilar cholangiocarcinoma,including serum CEA levels(x2=14.56,P =0.004),surgical procedure(x2=22.49,P 0.001) and TNM stage(x2=12.31,P =0.005).The average survival times of serum CEA positive and negative were(7.1 ± 5.6) months and(17.2 ± 9.2) months,and there was significant difference(P 0.05).The average survival times of hilar cholangiocarcinoma with radical resection,palliative resection,simple drainage and without treatment were(17.1 ± 9.6) months,(10.6 ± 4.2) months,(7.4 ± 2.5) months and(3.4 ± 1.4) months,and there was significant statistic difference(P 0.05).The average survival times of Stage I,Stage II,Stage III,Stage IVa and Stage IVb were(18.5 ± 5.9) months,(16.7 ± 10.0)months,(13.2 ± 8.7) months,(10.9 ± 7.4) months,and(8.3 ± 6.3) months,and there was significant difference(P 0.05).Conclusion The prognosis of hilar cholangiocarcinoma patient with normal serum CEA,radical resection and Stage I are much better.
出处 《肝胆胰外科杂志》 CAS 2012年第2期92-95,共4页 Journal of Hepatopancreatobiliary Surgery
关键词 肝门胆管癌 预后 多因素回归分析 hilar cholangiocarcinoma prognosis multi-factor regression analysis
  • 相关文献

参考文献13

  • 1Vauthey JN,Blumgart LH. Recent advances in the management of cholangiocarcinomas[J].Seminars in Liver Disease,1994,(02):109-114.doi:10.1055/s-2007-1007302.
  • 2Ohshio G,Mnabae T,Wetarbae Y. Comparative studies of DUPAN2,careinoembryotic antigen and CA199 in the serum and bile patients with pancreatic and biliary tract disease:evaluation of the influence of obsturetive jaundice[J].American Journal of Gastroenterology,1990,(10):1370-1376.
  • 3Lim JH,Park CK. Pathology of cholangiocarcinoma[J].Abdominal Imaging,2004,(05):540-547.
  • 4麻勇,许军,代文杰.肝门部胆管癌诊治进展[J].肝胆胰外科杂志,2005,17(4):343-346. 被引量:5
  • 5Nakeeb A,Lipsett PA,Lillemoe KD. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma[J].American Journal of Surgery,1996,(01):147-153.doi:10.1016/S0002-9610(99)80090-7.
  • 6陈汝福.细胞凋亡在肝胆肿瘤形成和治疗中的意义[J].国外医学(肿瘤学分册),1997,24(2):90-92. 被引量:17
  • 7Chamberlain RS,Blumgart LH. The surgical approach to cholangiocarcinoma[J].Curr Med Lit Gastroenterol,1999,(03):24-40.
  • 8Yoshimi F,Asato Y,Amemiya R. Comparison between pancreatoduodenectomy and hepatopancreatoduodenectomy for bile duct cancer[J].Hepato-Gastroenterology,2001,(40):994-998.
  • 9黄志强.提高肝门部胆管癌手术治疗效果的措施[J].中国实用外科杂志,1998,18(6):325-326. 被引量:54
  • 10Miyazaki M,Ito H,Nakagawa K. Aggressive surgical approach to hilar cholangiocarcinoma:hepatic or local resection[J].Surgery,1998,(02):131.doi:10.1016/S0039-6060(98)70249-1.

二级参考文献6

共引文献112

同被引文献91

引证文献9

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部